PsyIndex Weekly Update

June 14, 2021 – June 18, 2021
The PsyIndex gave up ground last week following the prior week’s robust gains. ATAI Life Sciences N.V. (NASDAQ: ATAI) began the new week on a positive note with a nearly 3% gain by mid-session while the Horizons Psychedelic Stock Index ETF (NEO: PSYK) moved marginally lower.

Market Performance

Weekly Performance: $134.28 (-4.39%)

Powered by

CFN Enterprises Inc. (OTCQB: CNFN)

Top Gainers

Top Decliners

View All Index Constituents

Corporate News, Deals & Listings

  • eHave Inc. (OTC: EHVVF) adds Dr. Jeffrey Kamlet, an expert on cardiac safety in ibogaine treatment, as Chief Medical Officer. Press Release
  • Entheon Biomedical Corp. (CSE: ENBI) announces agreement to acquire Lobo Genetics Inc. Press Release
  • Wake Network Inc. retains CRO Sante Cannabis to conduct clinical trials in psilocybin therapies. Press Release
  • AREV Nanotec Brands Inc. (CSE: AREV) completes land survey and soil analysis for cultivation of mushrooms and moringa. Press Release
  • Mydecine Innovations Group Inc. (NEO: MYCO) plans to leverage AI and ML to accelerate its research and development. Press Release
Read More

Featured Content

3 Ways to Invest in AI & Machine Learning

We take a look at a handful of ways to invest in machine learning and artificial intelligence, including cutting-edge mental health applications that combine AI with psychedelics to produce better outcomes.

Industry Developments

  • Texas will study the benefits of psychedelics for military veterans under a bill enacted without the governor’s signature. via Marijuana Moment
  • British Columbia researchers harness the ‘magic’ of psychedelic mushrooms for mental health disorders. via CBC
  • 3 psychedelic stocks getting high thanks to the newly launched psychedelics ETF. via Investor Place
Visit the PsyIndex